Although control of EBV infection by the immune system has been mainly attributed to CD8 T cells and to a lesser extent to NK cells, a role for humoral immunity in protecting from EBV infection has recently been reevaluated with a focus on IM patients (46–48). This evidence concerns the gene CD8A and Epstein-Barr virus infection.